A Contemporary Picture of Enterococcal Endocarditis
- PMID: 32029130
- DOI: 10.1016/j.jacc.2019.11.047
A Contemporary Picture of Enterococcal Endocarditis
Erratum in
-
Correction.J Am Coll Cardiol. 2020 Jun 16;75(23):2998-3000. doi: 10.1016/j.jacc.2020.05.004. J Am Coll Cardiol. 2020. PMID: 32527411 No abstract available.
Abstract
Background: Enterococcal endocarditis (EE) is a growing entity in Western countries. However, quality data from large studies is lacking.
Objectives: The purpose of this study was to describe the characteristics and analyze the prognostic factors of EE in the GAMES cohort.
Methods: This was a post hoc analysis of a prospectively collected cohort of patients from 35 Spanish centers from 2008 to 2016. Characteristics and outcomes of 516 cases of EE were compared with those of 3,308 cases of nonenterococcal endocarditis (NEE). Logistic regression and Cox proportional hazards regression analysis were performed to investigate risk factors for in-hospital and 1-year mortality, as well as relapses.
Results: Patients with EE were significantly older; more frequently presented chronic lung disease, chronic heart failure, prior endocarditis, and degenerative valve disease; and had higher median age-adjusted Charlson score. EE more frequently involved the aortic valve and prosthesis (64.3% vs. 46.7%; p < 0.001; and 35.9% vs. 28.9%; p = 0.002, respectively) but less frequently pacemakers/defibrillators (1.5% vs. 10.5%; p < 0.001), and showed higher rates of acute heart failure (45% vs. 38.3%; p = 0.005). Cardiac surgery was less frequently performed in EE (40.7% vs. 45.9%; p = 0.024). No differences in in-hospital and 1-year mortality were found, whereas relapses were significantly higher in EE (3.5% vs. 1.7%; p = 0.035). Increasing Charlson score, LogEuroSCORE, acute heart failure, septic shock, and paravalvular complications were risk factors for mortality, whereas prior endocarditis was protective and persistent bacteremia constituted the sole risk factor for relapse.
Conclusions: Besides other baseline and clinical differences, EE more frequently affects prosthetic valves and less frequently pacemakers/defibrillators. EE presents higher rates of relapse than NEE.
Trial registration: ClinicalTrials.gov NCT00871104.
Keywords: enterococci; epidemiology; heart failure; infective endocarditis; prosthetic valves; relapses.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
-
Addressing the Menace of Enterococcal Endocarditis.J Am Coll Cardiol. 2020 Feb 11;75(5):495-497. doi: 10.1016/j.jacc.2019.12.009. J Am Coll Cardiol. 2020. PMID: 32029131 No abstract available.
-
The Need for Quality and Unbiased Data in Infective Endocarditis.J Am Coll Cardiol. 2020 Jun 16;75(23):2993-2994. doi: 10.1016/j.jacc.2020.02.072. J Am Coll Cardiol. 2020. PMID: 32527407 No abstract available.
-
Reply: The Need for Quality and Unbiased Data in Infective Endocarditis.J Am Coll Cardiol. 2020 Jun 16;75(23):2994-2995. doi: 10.1016/j.jacc.2020.04.034. J Am Coll Cardiol. 2020. PMID: 32527408 No abstract available.
Similar articles
-
Enterococcal endocarditis on native and prosthetic valves: a review of clinical and prognostic factors with emphasis on hospital-acquired infections as a major determinant of outcome.Medicine (Baltimore). 2007 Nov;86(6):363-377. doi: 10.1097/MD.0b013e31815d5386. Medicine (Baltimore). 2007. PMID: 18004181
-
[Enterococcal endocarditis: a multicenter study of 76 cases].Enferm Infecc Microbiol Clin. 2009 Dec;27(10):571-9. doi: 10.1016/j.eimc.2009.02.007. Epub 2009 May 24. Enferm Infecc Microbiol Clin. 2009. PMID: 19477041 Spanish.
-
A Contemporary Picture of Coagulase-Negative Staphylococcal Endocarditis: A Nationwide GAMES Cohort Study.J Am Coll Cardiol. 2025 Feb 4;85(4):305-318. doi: 10.1016/j.jacc.2024.09.027. Epub 2024 Nov 22. J Am Coll Cardiol. 2025. PMID: 39580721
-
Infective endocarditis post-transcatheter aortic valve implantation (TAVI), microbiological profile and clinical outcomes: A systematic review.PLoS One. 2020 Jan 17;15(1):e0225077. doi: 10.1371/journal.pone.0225077. eCollection 2020. PLoS One. 2020. PMID: 31951610 Free PMC article.
-
Isolated pulmonic valve infective endocarditis: a persistent challenge.Infection. 2004 Jun;32(3):170-5. doi: 10.1007/s15010-004-3022-3. Infection. 2004. PMID: 15188078 Review.
Cited by
-
High-Dose Ceftriaxone in Elderly Patients with Enterococcal Infective Endocarditis: Population Pharmacokinetics of Free Ceftriaxone and Dose Optimization.Antibiotics (Basel). 2025 May 15;14(5):508. doi: 10.3390/antibiotics14050508. Antibiotics (Basel). 2025. PMID: 40426574 Free PMC article.
-
Outcomes of Enterococcus faecalis infective endocarditis according to MIC of amoxicillin: a multicentric study.JAC Antimicrob Resist. 2024 Nov 1;6(6):dlae167. doi: 10.1093/jacamr/dlae167. eCollection 2024 Dec. JAC Antimicrob Resist. 2024. PMID: 39493937 Free PMC article.
-
Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates.J Antimicrob Chemother. 2024 Apr 2;79(4):801-809. doi: 10.1093/jac/dkae032. J Antimicrob Chemother. 2024. PMID: 38334390 Free PMC article.
-
Factors associated with persistent bacteraemia among patients with suspected infective endocarditis.Infection. 2025 Apr 7. doi: 10.1007/s15010-025-02537-5. Online ahead of print. Infection. 2025. PMID: 40192959
-
Current Knowledge of Enterococcal Endocarditis: A Disease Lurking in Plain Sight of Health Providers.Pathogens. 2024 Mar 7;13(3):235. doi: 10.3390/pathogens13030235. Pathogens. 2024. PMID: 38535578 Free PMC article. Review.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical